Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Automation of human pluripotent stem cell differentiation toward retinal pigment epithelial cells for large-scale productions.

Regent F, Morizur L, Lesueur L, Habeler W, Plancheron A, Ben M'Barek K, Monville C.

Sci Rep. 2019 Jul 23;9(1):10646. doi: 10.1038/s41598-019-47123-6.

2.

Cell Therapy for Retinal Dystrophies: From Cell Suspension Formulation to Complex Retinal Tissue Bioengineering.

Ben M'Barek K, Monville C.

Stem Cells Int. 2019 Jan 23;2019:4568979. doi: 10.1155/2019/4568979. eCollection 2019. Review.

3.

Engineering Transplantation-suitable Retinal Pigment Epithelium Tissue Derived from Human Embryonic Stem Cells.

Ben M'Barek K, Habeler W, Plancheron A, Jarraya M, Goureau O, Monville C.

J Vis Exp. 2018 Sep 6;(139). doi: 10.3791/58216.

PMID:
30247475
4.

hRPE cells derived from induced pluripotent stem cells are more sensitive to oxidative stress than ARPE-19 cells.

Voisin A, Monville C, Plancheron A, Balbous A, Gaillard A, Leveziel N.

Exp Eye Res. 2018 Dec;177:76-86. doi: 10.1016/j.exer.2018.07.017. Epub 2018 Jul 24.

PMID:
30048622
5.

[Treating retinal dystrophies affecting retinal pigment epithelium using tissue engineering obtained from human embryonic stem cells].

Ben M'Barek K, Habeler W, Goureau O, Monville C.

Med Sci (Paris). 2018 May;34(5):383-386. doi: 10.1051/medsci/20183405004. Epub 2018 Jun 13. French. No abstract available.

6.

Stem Cell-Based RPE Therapy for Retinal Diseases: Engineering 3D Tissues Amenable for Regenerative Medicine.

Ben M'Barek K, Habeler W, Monville C.

Adv Exp Med Biol. 2018;1074:625-632. doi: 10.1007/978-3-319-75402-4_76. Review.

PMID:
29721996
7.

Human ESC-derived retinal epithelial cell sheets potentiate rescue of photoreceptor cell loss in rats with retinal degeneration.

Ben M'Barek K, Habeler W, Plancheron A, Jarraya M, Regent F, Terray A, Yang Y, Chatrousse L, Domingues S, Masson Y, Sahel JA, Peschanski M, Goureau O, Monville C.

Sci Transl Med. 2017 Dec 20;9(421). pii: eaai7471. doi: 10.1126/scitranslmed.aai7471.

PMID:
29263231
8.

[The school doctorand suspected child abuse : towards good practice recommendations in the child's interest].

Noirhomme-Renard F, Blavier A, Lachaussée S, Monville C, Nihoul C, Gosset C.

Rev Med Liege. 2016 Oct;71(10):428-434. Review. French.

9.

Use of human pluripotent stem cells to study and treat retinopathies.

Ben M'Barek K, Regent F, Monville C.

World J Stem Cells. 2015 Apr 26;7(3):596-604. doi: 10.4252/wjsc.v7.i3.596. Review.

10.

Impact of lauric arginate application form on its antimicrobial activity on the surface of a model meat product.

Terjung N, Monville C, Loeffler M, Gibis M, Hinrichs J, Weiss J.

J Food Sci. 2014 Oct;79(10):M2056-65. doi: 10.1111/1750-3841.12641. Epub 2014 Sep 16.

PMID:
25227890
11.

From confluent human iPS cells to self-forming neural retina and retinal pigmented epithelium.

Reichman S, Terray A, Slembrouck A, Nanteau C, Orieux G, Habeler W, Nandrot EF, Sahel JA, Monville C, Goureau O.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8518-23. doi: 10.1073/pnas.1324212111. Epub 2014 May 27.

12.

Human induced pluripotent stem cells as a tool to model a form of Leber congenital amaurosis.

Lustremant C, Habeler W, Plancheron A, Goureau O, Grenot L, de la Grange P, Audo I, Nandrot EF, Monville C.

Cell Reprogram. 2013 Jun;15(3):233-46. doi: 10.1089/cell.2012.0076. Epub 2013 May 10.

PMID:
23663011
13.

Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissue.

Habeler W, Ghaleh B, Barthelemy I, Plancheron A, Bizé A, Carlos-Sampedrano C, Chetboul V, Berdeaux A, Pucéat M, Peschanski M, Blot S, Monville C.

J Stem Cells Regen Med. 2011 Oct 30;7(2):80-6. eCollection 2011.

14.

Organotypic heart slices for cell transplantation and physiological studies.

Habeler W, Peschanski M, Monville C.

Organogenesis. 2009 Apr;5(2):62-6.

15.

Genetic, temporal and diurnal influences on L-dopa-induced dyskinesia in the 6-OHDA model.

Monville C, Torres EM, Pekarik V, Lane EL, Dunnett SB.

Brain Res Bull. 2009 Mar 16;78(4-5):248-53. doi: 10.1016/j.brainresbull.2008.11.007. Epub 2008 Dec 12.

PMID:
19070653
16.

An in vitro beating heart model for long-term assessment of experimental therapeutics.

Habeler W, Pouillot S, Plancheron A, Pucéat M, Peschanski M, Monville C.

Cardiovasc Res. 2009 Feb 1;81(2):253-9. doi: 10.1093/cvr/cvn299. Epub 2008 Nov 3.

PMID:
18980954
17.

Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease.

Torres EM, Monville C, Gates MA, Bagga V, Dunnett SB.

Neuroscience. 2007 Jun 8;146(4):1606-17. Epub 2007 May 2.

PMID:
17478050
18.

Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model.

Monville C, Torres EM, Dunnett SB.

J Neurosci Methods. 2006 Dec 15;158(2):219-23. Epub 2006 Jul 11.

PMID:
16837051
20.
21.
22.

Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model.

Dowd E, Monville C, Torres EM, Wong LF, Azzouz M, Mazarakis ND, Dunnett SB.

Eur J Neurosci. 2005 Nov;22(10):2587-95.

PMID:
16307601
23.

In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine system.

Torres EM, Monville C, Lowenstein PR, Castro MG, Dunnett SB.

Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):1-10. Epub 2005 Apr 18.

24.

HSV vector-delivery of GDNF in a rat model of PD: partial efficacy obscured by vector toxicity.

Monville C, Torres E, Thomas E, Scarpini CG, Muhith J, Lewis J, Finn J, Smith C, Cai S, Efstathiou S, Howard K, Dunnett SB.

Brain Res. 2004 Oct 22;1024(1-2):1-15.

PMID:
15451362
25.

Astroglial expression of the P-glycoprotein is controlled by intracellular CNTF.

Monville C, Fages C, Feyens AM, D'Hondt V, Guillet C, Vernallis A, Gascan H, Peschanski M.

BMC Cell Biol. 2002 Jul 31;3:20.

26.

Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.

Mittoux V, Ouary S, Monville C, Lisovoski F, Poyot T, Conde F, Escartin C, Robichon R, Brouillet E, Peschanski M, Hantraye P.

J Neurosci. 2002 Jun 1;22(11):4478-86.

27.

Gene therapy in Parkinson's disease: dream or reality?

Monville C.

Neuroreport. 2002 May 7;13(6):743. No abstract available.

PMID:
12030230
28.

Retinoic acid increases proliferation rate of GL-15 glioma cells, involving activation of STAT-3 transcription factor.

Paillaud E, Costa S, Fages C, Plassat JL, Rochette-Egly C, Monville C, Tardy M.

J Neurosci Res. 2002 Mar 1;67(5):670-9.

PMID:
11891779
29.

Ciliary neurotrophic factor may activate mature astrocytes via binding with the leukemia inhibitory factor receptor.

Monville C, Coulpier M, Conti L, De-Fraja C, Dreyfus P, Fages C, Riche D, Tardy M, Cattaneo E, Peschanski M.

Mol Cell Neurosci. 2001 Feb;17(2):373-84.

PMID:
11178874
30.

[Articular chondrocalcinosis after 80 years of age].

Memin Y, Monville C, Ryckewaert A.

Rev Rhum Mal Osteoartic. 1978 Feb;45(2):77-82. French.

PMID:
644241

Supplemental Content

Loading ...
Support Center